Please note: This trial has finished recruiting and is not accepting new participants.
Research Center: Medical University of South Carolina
Location: Charleston, SC, USA
Lead Doctor: Constance Guille, M.D., MSCR; Rubin Aujla, M.D., MPH
IRB Committee: This study has been reviewed and approved by MUSC Institutional Review Board

Background

There has been a significant rise in the number of women who struggle with opioid use during pregnancy. Examples of opioids include pain relief medication, fentanyl, heroin, oxycodone, morphine and hydrocodone. The use of opioids during pregnancy has been found to negatively impact the health of the mother and newborn. Researchers are working to develop effective strategies that may help reduce the need for opioids among pregnant women.

This research aims to gather feedback about a potential virtual screening program that may detect and help treat opioid misuse or use disorder among pregnant women. Researchers will collect feedback from participants through group discussions and individual interviews. 

This study is looking for pregnant women between the ages of 18 and 45 years old. Interested participants must be willing to attend a study visit that will last between 30 to 90 minutes. Participants may also be able to participate remotely. Eligible participants will be compensated.   

Why Participate? 

• You may contribute valuable information that may help pregnant women struggling with opioid use.
• You may have the option to learn about getting treatment, if you struggle with opioid use.
• You will be compensated up to $40 for participating in this study.
• You may help contribute to a research study on women’s health. 
• You will be helping to advance medical research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Pregnant women aged 18 to 45 years old.
• Must have a history of struggling with opioid use or opioid use disorder during pregnancy. 
• Able to attend 1 study visit that will last between 30 to 90 minutes.
  • Please note: The study may include either an individual interview or a focus group discussion. Individual interviews may be done remotely.